Cagri Senocak

Cagri Senocak

Auto-generated profile, based on publicly available information

Cagri Senocak

Department of Urology, Ankara Ataturk Sanatorium Training and Research Hospital, Ministry of Health, University of Health Sciences, Ankara, Turkey

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2021 in Minimally Invasive Therapy & Allied Technologies
Verified
Journal Article
Closed access
EDErman Damar
Erman Damar
CSCagri Senocak
Cagri Senocak
RORidvan Ozbek
Ridvan Ozbek
HHHakan Bahadır Haberal
Hakan Bahadır Haberal
FSFahri Erkan Sadioglu
Fahri Erkan Sadioglu
OBOmer Faruk Bozkurt
Omer Faruk Bozkurt
To evaluate whether or not using a ureteral access sheath (UAS) affects the perioperative outcomes after retrograde intrarenal surgery (RIRS) performed in patients with renal stones.An observationa...

12 July 2017 in Urolithiasis
Verified
Journal Article
Closed access
PDF file
CSCagri Senocak
Cagri Senocak
RORidvan Ozbek
Ridvan Ozbek
OBOmer Faruk Bozkurt
Omer Faruk Bozkurt
AUAli Unsal
Ali Unsal

1 October 2018 in Journal of Pediatric Urology
Verified
Journal Article
Closed access
CSC. Senocak
C. Senocak
ROR. Ozbek
R. Ozbek
YYY.E. Yildirim
Y.E. Yildirim
OBO.F. Bozkurt
O.F. Bozkurt
AUA. Unsal
A. Unsal

5 August 2024 in Journal of Pediatric Urology
Verified
Journal Article
Closed access
HAHayrettin Aslan
Hayrettin Aslan
CSCagri Senocak
Cagri Senocak
HHHakan Bahadır Haberal
Hakan Bahadır Haberal
FGFahrettin Gorkem Guvenir
Fahrettin Gorkem Guvenir
MIMuhammed Arif Ibis
Muhammed Arif Ibis
OBOmer Faruk Bozkurt
Omer Faruk Bozkurt

25 July 2013 in International Urology and Nephrology
Verified
Journal Article
Closed access
PDF file
AUAli Unsal
Ali Unsal
UOUral Oguz
Ural Oguz
ATAltug Tuncel
Altug Tuncel
OBOmer Faruk Bozkurt
Omer Faruk Bozkurt
YAYilmaz Aslan
Yilmaz Aslan
AAAli Atan
Ali Atan

1 March 2024 in Journal of Laparoendoscopic & Advanced Surgical Techniques
Verified
Journal Article
Closed access
HHHakan Bahadır Haberal
Hakan Bahadır Haberal
SASema Ayvaz
Sema Ayvaz
AKAli Said Kilicalp
Ali Said Kilicalp
FSFahri Erkan Sadioglu
Fahri Erkan Sadioglu
CSCagri Senocak
Cagri Senocak
OBOmer Faruk Bozkurt
Omer Faruk Bozkurt
Introduction: Mayo Adhesive Probability (MAP) score was developed as a means to predict the presence of adherent perinephric fat. Our aim was to determine the predictive value of the MAP score on surgical outcomes in patients undergoing standard adult percutaneous nephrolithotomy (PCNL). Materials and Methods: We retrospectively analyzed the data from 130 renal units that underwent PCNL between January 2022 and 2023. MAP scores 0–2 were classified as low, whereas MAP scores 3–5 were classified as high. The impact of the MAP score on perioperative and postoperative outcomes was studied. All statistical analyses were performed using SPSS 24.0 for Windows. Results: The median age of the patients at the time of surgery was 48 (21) years, with a female-to-male ratio of 1:1.82. The median MAP score was 2 (2), with 43.8% of patients falling into the high MAP score group. Advanced age, hypertension history, low estimated glomerular filtration rate (eGFR) levels, and low renal parenchymal thickness were significantly higher in the high MAP score group ( P = .010, P = .004, P = .001, and P = .005, respectively). Female patients had a significantly higher MAP score of 0 ( P = .021). Operation time, postoperative hematocrit decrease, blood transfusion rate, postoperative fever rate, hospitalization, and stone-free rates were comparable between the low and high MAP score groups ( P = .535, P = .209, P = .313, P = .289, P = .281, and P = .264, respectively). Gender and eGFR levels were shown to be significant predictors of a MAP ≥3 ( P = .004 and P = .003, respectively). Conclusion: The present study showed that the MAP score groups had similar perioperative and postoperative results. Low eGFR levels and the male gender were associated with MAP score ≥3. To determine the predictive MAP score value for PCNL outcomes, more prospective studies are needed.